Sai Sreyas Pharmaceutical Private Limited, a active private limited company, was established on 11 May 2010 in Hyderabad, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24232TG2010PTC068382. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹8.00 Cr.
It upholds a compliant status. Employing 66 professional, Its leadership includes Saraswathi Bakireddy (Director), Dileep Kumar Reddy Bakireddy (Director), Devereddy Vidna Reddy (Director). Past directors included Divya Bakireddy, Kiran Kumar Reddy Jambapuram, Devereddy Vidna Reddy. It holds ₹29.75 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at # 708,7Th Floor,Manjeera Trinity Corporate,Jntu To Hi-Tech City Road,3Rd Phase,Kphb Colony,, Kukatpally, Hyderabad, Telangana, 500072.
U24232TG2010PTC068382
068382
11 May 2010
₹10.00 Cr
₹8.00 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Sai Sreyas Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Saraswathi Bakireddy | Director | 19 Jun 2019 | Current |
| Dileep Kumar Reddy Bakireddy | Director | 21 Jan 2021 | Current |
| Devereddy Vidna Reddy | Director | 15 Dec 2011 | Current |
| Bakireddy Jayarami Reddy | Director | 17 Feb 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 20 Jun 2019 | Past |
| Pramod Abcsdd | Director | 20 Jun 2019 | Past |
| Pramod Abcsdd | Additional Director | 30 May 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sai Sreyas Pharmaceutical Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 7350.52% increase. The company also saw a substantial fall in profitability, with a 189.83% decrease in profit. The company's net worth Soared by an impressive increase of 113.12%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Sai Sreyas Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹297,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Aug 2021 | State Bank Of India | ₹29.75 Cr | Open |
Explore comprehensive loan charge details -
Sai Sreyas Pharmaceutical has a workforce of 66 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sai Sreyas Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sai Sreyas Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Sai Sreyas Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Sai Sreyas Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
Progress on A charge with State Bank Of India of Rs. 29.75 Cr registered on 09 Aug 2021 with Charge ID 100471970 was modified on 18 Apr 2022. was documented.
A charge with State Bank Of India amounted to Rs. 29.75 Cr with Charge ID 100471970 was registered on 09 Aug 2021. was recorded as a recent event.
Progress on Dileep Kumar Reddy Bakireddy was appointed as a Director was appointed as a Director on 21 Jan 2021 & has been associated with this company since 4 years 10 months . was documented.
Bakireddy Jayarami Reddy was appointed as a Director was appointed as a Director on 17 Feb 2020 & has been associated with this company since 5 years 9 months . was recorded as a recent event.
The CIN of Sai Sreyas Pharmaceutical Private Limited is U24232TG2010PTC068382.
Sai Sreyas Pharmaceutical Private Limited is headquartered at # 708,7Th Floor,Manjeera Trinity Corporate,Jntu To Hi-Tech City Road,3Rd Phase,Kphb Colony,, Kukatpally, Hyderabad, Telangana, 500072.
Sai Sreyas Pharmaceutical Private Limited was incorporated on 11 May 2010.
The current directors of Sai Sreyas Pharmaceutical Private Limited are
The primary industry of Sai Sreyas Pharmaceutical Private Limited is Manufacturing.
Sai Sreyas Pharmaceutical Private Limited is unlisted.
The authorized capital of Sai Sreyas Pharmaceutical Private Limited is ₹10.00 Cr, and the paid-up capital is ₹8.00 Cr.
The compliance status of Sai Sreyas Pharmaceutical Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX